Coe-Eisenberg, Taylor D.
Perissinotti, Anthony J.
Marini, Bernard L.
Pettit, Kristen M.
Bixby, Dale L.
Burke, Patrick W.
Benitez, Lydia http://orcid.org/0000-0001-6828-8053
Article History
Received: 8 April 2023
Accepted: 14 July 2023
First Online: 22 July 2023
Declarations
:
: This article does not contain any studies with human participants performed by any of the authors.
: Taylor Coe-Eisenberg, PharmD, declares no conflict of interest. Anthony J. Perissinotti, PharmD, has consulted or Servier, Amgen, and Pfizer pharmaceuticals. Bernard L. Marini, PharmD, has consulted for Servier. Kristen M. Pettit, MD, provides advising for the following companies: Kura Oncology, PharmaEssentia, CTI Biopharma. Dale L. Bixby, MD, Ph.D., declares no conflict of interest. Patrick W. Burke, MD, declares no conflict of interest. Lydia L. Benitez, PharmD, declares no conflict of interest.